These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8847017)

  • 1. Combined immunopharmaceutical therapy of patients with unresectable pancreatic carcinoma.
    Lygidakis NJ; Ziras FA; Kyparidou E; Parissis J; Papadopoulou P; Venetsanou B
    Hepatogastroenterology; 1995; 42(6):1039-52. PubMed ID: 8847017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy following pancreatic resection for pancreatic duct carcinoma: a prospective randomized study.
    Lygidakis NJ; Stringaris K
    Hepatogastroenterology; 1996; 43(9):671-80. PubMed ID: 8799414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic head carcinoma: is pancreatic resection indicated for patients with stage III pancreatic duct cancer?
    Lygidakis NJ; Papadopoulou P
    Hepatogastroenterology; 1995; 42(5):587-96. PubMed ID: 8751219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cell mediated immunity in advanced pancreatic carcinoma before and after treatment with interleukin-2 (IL-2).
    Abdel-Wahab M; El-Shennawy F; Agha S; Ragab E; Fathi O; Sultan A; Elghawalby N; Ezzat F
    Hepatogastroenterology; 1999 May; 46 Suppl 1():1293-6. PubMed ID: 10429977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre- and post- operative adjuvant targeting locoregional chemotherapy combined with locoregional targeting immunostimulation and surgical resection for hepatocellular carcinoma. A new promising alternative.
    Lygidakis NJ; Konstantinidou T; Pothoulakis J
    Anticancer Res; 1994; 14(3B):1351-5. PubMed ID: 8067704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unresectable pancreatic cancer: is a multi-modality approach a promising therapeutical alternative?
    Lygidakis NJ; Dedemati G; Spenzaris N; Theodoropoulou M
    Hepatogastroenterology; 1997; 44(16):1222-8. PubMed ID: 9261631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrasplenic immunostimulation in malignancies fact or fiction? Present and future.
    Lygidakis NJ; Spenzouris N; Dedemadi G; Kyriakou A; Theodorakopoulos M
    Hepatogastroenterology; 1998; 45(20):404-10. PubMed ID: 9638414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of radiation therapy combined with intra-arterial infusion chemotherapy in patients with non-resectable pancreatic cancer].
    Ohigashi H; Ishikawa O; Nakamori S; Masutani S; Sasaki Y; Kameyama M; Hiratsuka M; Kabuto T; Furukawa H; Imaoka S
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1682-4. PubMed ID: 1530331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consecutive re-explorations for final resection of initially unresectable pancreatic head carcinoma.
    Lygidakis NJ; Vlachos L; Raptis S; Sgourakis G; Mourikis D; Kehagias D
    Hepatogastroenterology; 1999; 46(28):2229-39. PubMed ID: 10521972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional chemotherapy in pancreatic cancer.
    Nazli O; Tansug T; Bozdag AD; Cln N; Kaymak E
    Hepatogastroenterology; 1999; 46(25):479-82. PubMed ID: 10228847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Locoregional and systemic therapy of advanced pancreatic carcinoma].
    Gebauer T; Ridwelski K; Fahlke J; Lippert H
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1344-7. PubMed ID: 9931877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma: a new alternative for an old problem.
    Lygidakis NJ; Kosmidis P; Ziras N; Parissis J; Kyparidou E
    J Interferon Cytokine Res; 1995 May; 15(5):467-72. PubMed ID: 7544232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional chemotherapy versus locoregional combined immuno-chemotherapy for patients with advanced metastatic liver disease of colorectal origin: a prospective randomized study.
    Lygidakis NJ; Stringaris K; Kokinis K; Lyberopoulos K; Raptis S
    Hepatogastroenterology; 1996; 43(7):212-20. PubMed ID: 8682466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy, bypass operation and celiac plexus block in patients with unresectable locally advanced pancreatic cancer.
    Yamaguchi K; Kobayashi K; Ogura Y; Nakamura K; Nakano K; Mizumoto K; Tanaka M
    Hepatogastroenterology; 2005; 52(65):1605-12. PubMed ID: 16201126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients.
    van Wagensveld BA; Coene PP; van Gulik TM; Rauws EA; Obertop H; Gouma DJ
    Br J Surg; 1997 Oct; 84(10):1402-6. PubMed ID: 9361599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined biliary and gastric bypass procedures as effective palliation for unresectable malignant disease.
    Mann CD; Thomasset SC; Johnson NA; Garcea G; Neal CP; Dennison AR; Berry DP
    ANZ J Surg; 2009 Jun; 79(6):471-5. PubMed ID: 19566872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical palliation combined with synchronous therapy in pancreatic carcinoma.
    Kahn PJ; Skornick Y; Inbar M; Kaplan O; Chaichik S; Rozin R
    Eur J Surg Oncol; 1990 Feb; 16(1):7-11. PubMed ID: 1689679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
    Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined arterial infusion and stent implantation compared with metal stent alone in treatment of malignant gastroduodenal obstruction.
    Wang Z; Chen K; Gong J; Zheng Y; Wang T
    Cardiovasc Intervent Radiol; 2009 Sep; 32(5):1011-8. PubMed ID: 19669831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.